PDB Short entry for 2O39 HEADER VIRAL PROTEIN/IMMUNE SYSTEM 01-DEC-06 2O39 TITLE HUMAN ADENOVIRUS TYPE 11 KNOB IN COMPLEX WITH DOMAINS SCR1 AND SCR2 OF TITLE 2 CD46 (MEMBRANE COFACTOR PROTEIN, MCP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBER PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 129-325; COMPND 5 SYNONYM: PIV; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: MEMBRANE COFACTOR PROTEIN; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: SCR1 AND SCR 2 DOMAINS; COMPND 11 SYNONYM: TROPHOBLAST LEUKOCYTE COMMON ANTIGEN, TLX, CD46 ANTIGEN; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN ADENOVIRUS 11P; SOURCE 3 ORGANISM_TAXID: 343462; SOURCE 4 STRAIN: SLOBISKI; SOURCE 5 GENE: PIV; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA 2 DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CD46, MCP; SOURCE 16 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 17 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 19 EXPRESSION_SYSTEM_CELL_LINE: CHO-LEC3281; SOURCE 20 EXPRESSION_SYSTEM_CELL: CHO CELL; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PBJ5 KEYWDS MEMBRANE COFACTOR PROTEIN, MCP, CD46, ADENOVIRUS, FIBER KNOB, AD11, KEYWDS 2 VIRUS RECEPTOR COMPLEX, SCR, SHORT CONSENSUS REPEAT, CCP, COMPLEMENT KEYWDS 3 CONTROL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.B.PERSSON,D.M.REITER,N.ARNBERG,T.STEHLE REVDAT 7 03-APR-24 2O39 1 REMARK REVDAT 6 27-DEC-23 2O39 1 HETSYN REVDAT 5 29-JUL-20 2O39 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 13-JUL-11 2O39 1 VERSN REVDAT 3 24-FEB-09 2O39 1 VERSN REVDAT 2 20-FEB-07 2O39 1 JRNL REVDAT 1 09-JAN-07 2O39 0 JRNL AUTH B.D.PERSSON,D.M.REITER,M.MARTTILA,Y.F.MEI,J.M.CASASNOVAS, JRNL AUTH 2 N.ARNBERG,T.STEHLE JRNL TITL ADENOVIRUS TYPE 11 BINDING ALTERS THE CONFORMATION OF ITS JRNL TITL 2 RECEPTOR CD46. JRNL REF NAT.STRUCT.MOL.BIOL. V. 14 164 2007 JRNL REFN ISSN 1545-9993 JRNL PMID 17220899 JRNL DOI 10.1038/NSMB1190 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 18738 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1869 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5134 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 34 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2O39 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040631. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : UNDULATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18738 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.13800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.2300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.32500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.640 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: HUMAN ADENOVIRUS TYPE 11 (UNPUBLISHED) CD46 SCR1 REMARK 200 AND SCR2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 35% PEG 200, 200MM CACL2, 100MM TRIS, REMARK 280 PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TRIMER CONSISTING OF THREE AD11 CHAINS AND THREE CD46 SCR1 REMARK 300 AND SCR2 CHAINS. THE ASYMMETRIC UNIT CONTAINS TWO COPIES OF AN AD11 REMARK 300 CHAIN, BELONGING TO DIFFERENT TRIMERS, AND TWO COPIES OF CD46, ALSO REMARK 300 BELONGING TO DIFFERENT TRIMERS. THE BIOLOGICAL UNITS, THE TRIMERS, REMARK 300 CAN BE CREATED THROUGH APPLICATION OF CRYSTALLOGRAPHIC SYMMETRY REMARK 300 OPERATORS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 53.07000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 91.91994 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -53.07000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 91.91994 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OH TYR A 319 OH TYR A 319 2665 1.90 REMARK 500 OH TYR B 319 OH TYR B 319 3555 1.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO D 5 C - N - CD ANGL. DEV. = -13.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 139 91.27 12.78 REMARK 500 SER A 150 20.50 -67.30 REMARK 500 SER A 153 93.90 74.39 REMARK 500 ASN A 154 94.67 25.32 REMARK 500 ASN A 192 130.62 173.72 REMARK 500 PRO A 215 160.32 -39.80 REMARK 500 SER A 238 128.41 -36.91 REMARK 500 ASP A 265 17.87 -67.89 REMARK 500 ASN A 278 70.64 10.62 REMARK 500 ASN A 283 -168.71 -179.54 REMARK 500 THR A 286 98.81 -66.92 REMARK 500 THR A 298 -168.25 -119.63 REMARK 500 PRO A 302 0.99 -65.54 REMARK 500 GLN A 305 -62.30 -19.39 REMARK 500 ALA A 308 155.98 -49.68 REMARK 500 THR A 309 -96.93 -154.61 REMARK 500 ASN B 139 91.99 12.05 REMARK 500 SER B 150 21.89 -67.27 REMARK 500 SER B 153 101.22 69.05 REMARK 500 ASN B 154 109.57 -3.38 REMARK 500 ASN B 192 132.24 173.70 REMARK 500 PRO B 215 160.78 -39.81 REMARK 500 SER B 238 129.61 -37.13 REMARK 500 ASP B 265 18.30 -68.34 REMARK 500 ASN B 278 71.06 9.38 REMARK 500 ASN B 283 -168.89 179.89 REMARK 500 THR B 286 98.70 -65.60 REMARK 500 THR B 298 -168.14 -119.84 REMARK 500 PRO B 302 2.08 -66.19 REMARK 500 GLN B 305 -62.30 -20.11 REMARK 500 ALA B 308 156.42 -49.21 REMARK 500 THR B 309 -96.84 -155.79 REMARK 500 GLU C 3 122.05 -30.79 REMARK 500 PRO C 4 159.01 -49.07 REMARK 500 ASP C 47 -168.41 -70.23 REMARK 500 HIS C 50 59.12 -68.99 REMARK 500 TRP C 52 154.96 -47.62 REMARK 500 LEU C 72 126.93 -23.25 REMARK 500 PRO C 78 88.71 -66.66 REMARK 500 ILE C 100 -95.59 -105.84 REMARK 500 GLU C 102 172.87 -32.15 REMARK 500 SER C 117 3.60 -67.09 REMARK 500 GLU D 2 93.51 46.17 REMARK 500 GLU D 3 97.63 77.40 REMARK 500 LYS D 31 -179.79 -65.11 REMARK 500 THR D 44 148.54 -174.16 REMARK 500 ARG D 48 -66.04 -27.27 REMARK 500 ASN D 49 -21.94 -38.44 REMARK 500 LEU D 53 157.59 -36.27 REMARK 500 PRO D 78 96.94 -66.05 REMARK 500 REMARK 500 THIS ENTRY HAS 51 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 152 SER A 153 -149.76 REMARK 500 SER A 153 ASN A 154 140.50 REMARK 500 ASN C 49 HIS C 50 -149.31 REMARK 500 GLU D 2 GLU D 3 134.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA C3081 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 57 OD2 REMARK 620 2 ASP C 58 OD1 118.5 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA D3082 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 70 OD1 REMARK 620 2 ASP C 70 OD2 42.2 REMARK 620 3 ALA C 76 O 67.3 109.4 REMARK 620 4 ASP D 70 OD1 93.0 66.3 124.0 REMARK 620 5 ALA D 76 O 150.9 109.0 141.5 73.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA D3081 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP D 57 OD1 REMARK 620 2 ASP D 58 OD1 78.2 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CKL RELATED DB: PDB REMARK 900 N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, REMARK 900 MCP) DBREF 2O39 A 129 325 UNP P35774 FIBP_ADE1P 129 325 DBREF 2O39 B 129 325 UNP P35774 FIBP_ADE1P 129 325 DBREF 2O39 C 1 126 UNP P15529 MCP_HUMAN 35 160 DBREF 2O39 D 1 126 UNP P15529 MCP_HUMAN 35 160 SEQRES 1 A 197 ASP ASN ILE ASN THR LEU TRP THR GLY VAL ASN PRO THR SEQRES 2 A 197 GLU ALA ASN CYS GLN ILE MET ASN SER SER GLU SER ASN SEQRES 3 A 197 ASP CYS LYS LEU ILE LEU THR LEU VAL LYS THR GLY ALA SEQRES 4 A 197 LEU VAL THR ALA PHE VAL TYR VAL ILE GLY VAL SER ASN SEQRES 5 A 197 ASN PHE ASN MET LEU THR THR HIS ARG ASN ILE ASN PHE SEQRES 6 A 197 THR ALA GLU LEU PHE PHE ASP SER THR GLY ASN LEU LEU SEQRES 7 A 197 THR ARG LEU SER SER LEU LYS THR PRO LEU ASN HIS LYS SEQRES 8 A 197 SER GLY GLN ASN MET ALA THR GLY ALA ILE THR ASN ALA SEQRES 9 A 197 LYS GLY PHE MET PRO SER THR THR ALA TYR PRO PHE ASN SEQRES 10 A 197 ASP ASN SER ARG GLU LYS GLU ASN TYR ILE TYR GLY THR SEQRES 11 A 197 CYS TYR TYR THR ALA SER ASP ARG THR ALA PHE PRO ILE SEQRES 12 A 197 ASP ILE SER VAL MET LEU ASN ARG ARG ALA ILE ASN ASP SEQRES 13 A 197 GLU THR SER TYR CYS ILE ARG ILE THR TRP SER TRP ASN SEQRES 14 A 197 THR GLY ASP ALA PRO GLU VAL GLN THR SER ALA THR THR SEQRES 15 A 197 LEU VAL THR SER PRO PHE THR PHE TYR TYR ILE ARG GLU SEQRES 16 A 197 ASP ASP SEQRES 1 B 197 ASP ASN ILE ASN THR LEU TRP THR GLY VAL ASN PRO THR SEQRES 2 B 197 GLU ALA ASN CYS GLN ILE MET ASN SER SER GLU SER ASN SEQRES 3 B 197 ASP CYS LYS LEU ILE LEU THR LEU VAL LYS THR GLY ALA SEQRES 4 B 197 LEU VAL THR ALA PHE VAL TYR VAL ILE GLY VAL SER ASN SEQRES 5 B 197 ASN PHE ASN MET LEU THR THR HIS ARG ASN ILE ASN PHE SEQRES 6 B 197 THR ALA GLU LEU PHE PHE ASP SER THR GLY ASN LEU LEU SEQRES 7 B 197 THR ARG LEU SER SER LEU LYS THR PRO LEU ASN HIS LYS SEQRES 8 B 197 SER GLY GLN ASN MET ALA THR GLY ALA ILE THR ASN ALA SEQRES 9 B 197 LYS GLY PHE MET PRO SER THR THR ALA TYR PRO PHE ASN SEQRES 10 B 197 ASP ASN SER ARG GLU LYS GLU ASN TYR ILE TYR GLY THR SEQRES 11 B 197 CYS TYR TYR THR ALA SER ASP ARG THR ALA PHE PRO ILE SEQRES 12 B 197 ASP ILE SER VAL MET LEU ASN ARG ARG ALA ILE ASN ASP SEQRES 13 B 197 GLU THR SER TYR CYS ILE ARG ILE THR TRP SER TRP ASN SEQRES 14 B 197 THR GLY ASP ALA PRO GLU VAL GLN THR SER ALA THR THR SEQRES 15 B 197 LEU VAL THR SER PRO PHE THR PHE TYR TYR ILE ARG GLU SEQRES 16 B 197 ASP ASP SEQRES 1 C 126 CYS GLU GLU PRO PRO THR PHE GLU ALA MET GLU LEU ILE SEQRES 2 C 126 GLY LYS PRO LYS PRO TYR TYR GLU ILE GLY GLU ARG VAL SEQRES 3 C 126 ASP TYR LYS CYS LYS LYS GLY TYR PHE TYR ILE PRO PRO SEQRES 4 C 126 LEU ALA THR HIS THR ILE CYS ASP ARG ASN HIS THR TRP SEQRES 5 C 126 LEU PRO VAL SER ASP ASP ALA CYS TYR ARG GLU THR CYS SEQRES 6 C 126 PRO TYR ILE ARG ASP PRO LEU ASN GLY GLN ALA VAL PRO SEQRES 7 C 126 ALA ASN GLY THR TYR GLU PHE GLY TYR GLN MET HIS PHE SEQRES 8 C 126 ILE CYS ASN GLU GLY TYR TYR LEU ILE GLY GLU GLU ILE SEQRES 9 C 126 LEU TYR CYS GLU LEU LYS GLY SER VAL ALA ILE TRP SER SEQRES 10 C 126 GLY LYS PRO PRO ILE CYS GLU LYS VAL SEQRES 1 D 126 CYS GLU GLU PRO PRO THR PHE GLU ALA MET GLU LEU ILE SEQRES 2 D 126 GLY LYS PRO LYS PRO TYR TYR GLU ILE GLY GLU ARG VAL SEQRES 3 D 126 ASP TYR LYS CYS LYS LYS GLY TYR PHE TYR ILE PRO PRO SEQRES 4 D 126 LEU ALA THR HIS THR ILE CYS ASP ARG ASN HIS THR TRP SEQRES 5 D 126 LEU PRO VAL SER ASP ASP ALA CYS TYR ARG GLU THR CYS SEQRES 6 D 126 PRO TYR ILE ARG ASP PRO LEU ASN GLY GLN ALA VAL PRO SEQRES 7 D 126 ALA ASN GLY THR TYR GLU PHE GLY TYR GLN MET HIS PHE SEQRES 8 D 126 ILE CYS ASN GLU GLY TYR TYR LEU ILE GLY GLU GLU ILE SEQRES 9 D 126 LEU TYR CYS GLU LEU LYS GLY SER VAL ALA ILE TRP SER SEQRES 10 D 126 GLY LYS PRO PRO ILE CYS GLU LYS VAL MODRES 2O39 ASN C 80 ASN GLYCOSYLATION SITE MODRES 2O39 ASN D 80 ASN GLYCOSYLATION SITE HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET CA C3081 1 HET CA D3081 1 HET CA D3082 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM CA CALCIUM ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 5 NAG 4(C8 H15 N O6) FORMUL 5 BMA 2(C6 H12 O6) FORMUL 7 CA 3(CA 2+) FORMUL 10 HOH *34(H2 O) HELIX 1 1 SER A 179 MET A 184 1 6 HELIX 2 2 LEU A 185 HIS A 188 5 4 HELIX 3 3 ASN A 231 MET A 236 5 6 HELIX 4 4 ARG A 249 GLU A 252 5 4 HELIX 5 5 SER B 179 MET B 184 1 6 HELIX 6 6 LEU B 185 HIS B 188 5 4 HELIX 7 7 ASN B 231 MET B 236 5 6 HELIX 8 8 ARG B 249 GLU B 252 5 4 SHEET 1 A 4 THR A 133 TRP A 135 0 SHEET 2 A 4 CYS A 156 THR A 165 -1 O LEU A 162 N LEU A 134 SHEET 3 A 4 LEU A 168 GLY A 177 -1 O ILE A 176 N LYS A 157 SHEET 4 A 4 PHE A 316 ILE A 321 -1 O PHE A 318 N ALA A 171 SHEET 1 B 4 ASN A 190 PHE A 199 0 SHEET 2 B 4 TYR A 288 ASN A 297 -1 O ILE A 292 N ALA A 195 SHEET 3 B 4 ALA A 268 LEU A 277 -1 N ASP A 272 O SER A 295 SHEET 4 B 4 TYR A 254 THR A 262 -1 N CYS A 259 O ILE A 271 SHEET 1 C 2 LYS A 219 SER A 220 0 SHEET 2 C 2 ASN A 223 MET A 224 -1 O ASN A 223 N SER A 220 SHEET 1 D 4 THR B 133 TRP B 135 0 SHEET 2 D 4 CYS B 156 THR B 165 -1 O LEU B 162 N LEU B 134 SHEET 3 D 4 LEU B 168 GLY B 177 -1 O ILE B 176 N LYS B 157 SHEET 4 D 4 PHE B 316 ILE B 321 -1 O PHE B 316 N VAL B 173 SHEET 1 E 4 ASN B 190 PHE B 199 0 SHEET 2 E 4 TYR B 288 ASN B 297 -1 O ILE B 292 N ALA B 195 SHEET 3 E 4 ALA B 268 LEU B 277 -1 N ASP B 272 O SER B 295 SHEET 4 E 4 TYR B 254 THR B 262 -1 N TYR B 261 O PHE B 269 SHEET 1 F 2 LYS B 219 SER B 220 0 SHEET 2 F 2 ASN B 223 MET B 224 -1 O ASN B 223 N SER B 220 SHEET 1 G 3 MET C 10 LEU C 12 0 SHEET 2 G 3 ARG C 25 CYS C 30 -1 O LYS C 29 N GLU C 11 SHEET 3 G 3 HIS C 43 ILE C 45 -1 O THR C 44 N VAL C 26 SHEET 1 H 2 TYR C 34 TYR C 36 0 SHEET 2 H 2 CYS C 60 ARG C 62 -1 O TYR C 61 N PHE C 35 SHEET 1 I 4 GLY C 74 VAL C 77 0 SHEET 2 I 4 TYR C 87 CYS C 93 -1 O HIS C 90 N VAL C 77 SHEET 3 I 4 ILE C 104 LEU C 109 -1 O LEU C 105 N MET C 89 SHEET 4 I 4 ALA C 114 TRP C 116 -1 O ILE C 115 N GLU C 108 SHEET 1 J 2 TYR C 98 LEU C 99 0 SHEET 2 J 2 CYS C 123 GLU C 124 -1 O GLU C 124 N TYR C 98 SHEET 1 K 3 MET D 10 LEU D 12 0 SHEET 2 K 3 ARG D 25 CYS D 30 -1 O LYS D 29 N GLU D 11 SHEET 3 K 3 HIS D 43 ILE D 45 -1 O THR D 44 N VAL D 26 SHEET 1 L 2 TYR D 34 TYR D 36 0 SHEET 2 L 2 CYS D 60 ARG D 62 -1 O TYR D 61 N PHE D 35 SHEET 1 M 4 GLY D 74 PRO D 78 0 SHEET 2 M 4 TYR D 87 CYS D 93 -1 O HIS D 90 N VAL D 77 SHEET 3 M 4 ILE D 104 LEU D 109 -1 O LEU D 105 N MET D 89 SHEET 4 M 4 ALA D 114 ILE D 115 -1 O ILE D 115 N GLU D 108 SHEET 1 N 2 TYR D 97 LEU D 99 0 SHEET 2 N 2 CYS D 123 LYS D 125 -1 O GLU D 124 N TYR D 98 SSBOND 1 CYS C 1 CYS C 46 1555 1555 2.04 SSBOND 2 CYS C 30 CYS C 60 1555 1555 2.04 SSBOND 3 CYS C 65 CYS C 107 1555 1555 2.03 SSBOND 4 CYS C 93 CYS C 123 1555 1555 2.06 SSBOND 5 CYS D 1 CYS D 46 1555 1555 0.79 SSBOND 6 CYS D 30 CYS D 60 1555 1555 2.04 SSBOND 7 CYS D 65 CYS D 107 1555 1555 2.04 SSBOND 8 CYS D 93 CYS D 123 1555 1555 2.15 LINK ND2 ASN C 80 C1 NAG E 1 1555 1555 1.46 LINK ND2 ASN D 80 C1 NAG F 1 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.38 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.38 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.39 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.38 LINK OD2 ASP C 57 CA CA C3081 1555 1555 2.78 LINK OD1 ASP C 58 CA CA C3081 1555 1555 2.83 LINK OD1 ASP C 70 CA CA D3082 1546 1555 2.69 LINK OD2 ASP C 70 CA CA D3082 1546 1555 3.25 LINK O ALA C 76 CA CA D3082 1546 1555 3.04 LINK OD1 ASP D 57 CA CA D3081 1555 1555 2.66 LINK OD1 ASP D 58 CA CA D3081 1555 1555 3.00 LINK OD1 ASP D 70 CA CA D3082 1555 1555 2.83 LINK O ALA D 76 CA CA D3082 1555 1555 2.72 CISPEP 1 PRO C 38 PRO C 39 0 -0.64 CISPEP 2 PRO D 38 PRO D 39 0 -1.53 CRYST1 106.140 106.140 68.320 90.00 90.00 120.00 P 3 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009422 0.005440 0.000000 0.00000 SCALE2 0.000000 0.010879 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014637 0.00000